| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
3,410 |
2,950 |
$207K |
| S9083 |
Global fee urgent care centers |
721 |
629 |
$94K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
835 |
746 |
$65K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
2,669 |
2,319 |
$33K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
524 |
445 |
$28K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
4,405 |
1,902 |
$19K |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
217 |
157 |
$12K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
170 |
163 |
$12K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
2,149 |
1,809 |
$9K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
29 |
28 |
$353.08 |
| 87807 |
|
64 |
58 |
$314.40 |
| 99051 |
|
20 |
20 |
$203.30 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
119 |
92 |
$62.35 |
| 81003 |
|
118 |
61 |
$51.96 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
26 |
14 |
$12.60 |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
663 |
415 |
$0.00 |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
38 |
31 |
$0.00 |
| S9088 |
Services provided in an urgent care center (list in addition to code for service) |
128 |
116 |
$0.00 |